Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001005477-07-003979
Filing Date
2007-07-12
Accepted
2007-07-12 17:12:04
Documents
2
Period of Report
2007-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 edgar123.html 3  
1 FORM 3 edgar123.xml 3 1474
2 POWER OF ATTORNEY powerofattorney.txt EX-24 3148
  Complete submission text file 0001005477-07-003979.txt   6724
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 972-4-988-9488
Gross Yodfat Harel (Reporting) CIK: 0001406333 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 07976954